The Importance of Quality Assurance in Radiation Oncology Clinical Trials
Thomas J. FitzGerald(University of Massachusetts Chan Medical School), Jeff M. Michalski(Washington University in St. Louis), Kenneth Ulin(University of Massachusetts Chan Medical School), M. Giulia Cicchetti(Providence College), Michael V. Knopp(University of California, Los Angeles), Stephen F. Kry(The University of Texas MD Anderson Cancer Center), Fred Prior(Mallinckrodt (United States)), Maryann Bishop‐Jodoin(Health Insurance Review and Assessment Service), Joel Saltz(Stony Brook Medicine), Linda Ding(University of Massachusetts Chan Medical School), Ying Xiao(Economic Research Institute), Koren Smith(University of Massachusetts Chan Medical School), Mark Rosen(California University of Pennsylvania), Fran Laurie(University of Massachusetts Chan Medical School), Matthew Iandoli(Calista Therapeutics (United States)), Janaki Moni(Yazaki (United States))
Cited by 6
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
|Cell Reports|2018|1.1k
IMRT commissioning: Multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119
|Medical Physics|2009|1k
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
|Journal of Clinical Oncology|2010|806
The Immune Landscape of Cancer
|Immunity|2019|806